30 filings
8-K
SRNEQ
Sorrento Therapeutics, Inc.
20 Dec 19
SORRENTO Announces Dr. Robin Smith as new member of the board of directors
4:09pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
9 Dec 19
SORRENTO Announces new board member
7:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
25 Nov 19
Sorrento Therapeutics, Inc. Received and Rejected Unsolicited All Cash Acquisition Proposal
7:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
9 Oct 19
SORRENTO THERAPEUTICS ANNOUNCES Closing of $25 MILLION REGISTERED DIRECT OFFERING
11:46am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
8 Oct 19
Sorrento Therapeutics Announces $25 Million Registered Direct Offering
4:18pm
8-K
7nvy1j
1 Oct 19
Entry into a Material Definitive Agreement
4:32pm
8-K
9jgqpn
1 Oct 19
Entry into a Material Definitive Agreement
4:28pm
8-K
amribervtd
23 Sep 19
Scilex Holding ANNOUNCEs Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
7:00am
8-K
qght0z02 y7lzu
23 Sep 19
Departure of Directors or Certain Officers
6:06am
8-K
gct4w0esr7kmpe4p2xlx
12 Aug 19
Other Events
10:10am
8-K
kbg6rgn8n i0r3i
12 Aug 19
Other Events
10:07am
8-K
kl4vf
2 Jul 19
Other Events
12:52pm
8-K
l1esr1mc02oxdonkota
28 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
eaeqjuhc cdbr5jbfc
20 Jun 19
Other Events
7:00am
8-K
qd2 2jipzw5miod
19 Jun 19
Sorrento PROVIDEs updates ON CD38 IMMUNOTHERApiEs and implementation of disruptive GMP manufacturing for “Off-the-shelf” cell therapy
7:00am
8-K
6eslzc
17 Jun 19
Termination of a Material Definitive Agreement
4:40pm
8-K
dgulv0l2
17 Jun 19
Other Events
9:22am
8-K
3fxpwkgnxzd1pqgxd10
12 Jun 19
Sorrento To Explore Potential Initial Public Offering of Scilex Holding Company
7:00am
8-K
9y10s8z6m 7dbiwzy3
5 Jun 19
Scilex Holding ANNOUNCEs strong Ztlido sales growth after successful post-merger integration
7:00am
8-K
9n524isn1599 njttb
4 Jun 19
Sorrento announces Cannabidiol (CBD) global joint ventures and commercial strategic partnerships
7:00am